
CaaMTech Secures Patent for Psilocybin and Cannabis Combination Therapy
CaaMTech secures a patent for a groundbreaking therapy combining psilocybin and cannabinoids, marking a significant step in psychedelic drug development
- •CaaMTech receives patent for psilocybin-cannabinoid therapy
- •Research shows synergistic effects on serotonin receptors
- •Patent approval supports future clinical trials and FDA approval
- •Challenges remain in developing combined compounds
by chercheurs-combiner-psilocybine-cannabis-medical



















